These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 313402

  • 1. An unique form of osteomalacia associated with end organ refractoriness to 1,25-dihydroxyvitamin D and apparent defective synthesis of 25-hydroxyvitamin D.
    Zerwekh JE, Glass K, Jowsey J, Pak CY.
    J Clin Endocrinol Metab; 1979 Aug; 49(2):171-5. PubMed ID: 313402
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK, Lyles KW, Haussler MR, Harrelson JM.
    J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
    [Abstract] [Full Text] [Related]

  • 4. Vitamin D metabolites in serum from hypoparathyroid patients treated with vitamin D2 and 1 alpha-hydroxyvitamin D3.
    Aksnes L, Aarskog D.
    J Clin Endocrinol Metab; 1980 Oct; 51(4):823-9. PubMed ID: 6968318
    [Abstract] [Full Text] [Related]

  • 5. An unusual form of vitamin D-dependent rickets in a child: alopecia and marked end-organ hyposensitivity to biologically active vitamin D.
    Tsuchiya Y, Matsuo N, Cho H, Kumagai M, Yasaka A, Suda T, Orimo H, Shiraki M.
    J Clin Endocrinol Metab; 1980 Oct; 51(4):685-90. PubMed ID: 6252222
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Effect of vitamin D 2 and 25-hydroxycholecalciferol on intestinal absorption of radiophosphate in man].
    Gennari C, Vattimo A, Nardi P.
    Boll Soc Ital Biol Sper; 1975 Feb 15; 51(3):86-9. PubMed ID: 1080052
    [No Abstract] [Full Text] [Related]

  • 9. Vitamin-D-dependent rickets type II. Resistance of target organs to 1,25-dihydroxyvitamin D.
    Brooks MH, Bell NH, Love L, Stern PH, Orfei E, Queener SF, Hamstra AJ, DeLuca HF.
    N Engl J Med; 1978 May 04; 298(18):996-9. PubMed ID: 205789
    [Abstract] [Full Text] [Related]

  • 10. Vitamin D metabolites and calcium metabolism in patients with nephrotic syndrome and normal renal function.
    Goldstein DA, Haldimann B, Sherman D, Norman AW, Massry SG.
    J Clin Endocrinol Metab; 1981 Jan 04; 52(1):116-21. PubMed ID: 6969729
    [Abstract] [Full Text] [Related]

  • 11. Differences in mineral metabolism among nonhuman primates receiving diets with only vitamin D3 or only vitamin D2.
    Marx SJ, Jones G, Weinstein RS, Chrousos GP, Renquist DM.
    J Clin Endocrinol Metab; 1989 Dec 04; 69(6):1282-90. PubMed ID: 2555385
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Vitamin D and vitamin D dependency.
    Tsuchiya Y, Matsuo N, Cho H, Tsubouchi K, Kumagai M, Nishii Y, Nanjoh M, Yamamoto T.
    Contrib Nephrol; 1980 Dec 04; 22():89-100. PubMed ID: 6967387
    [Abstract] [Full Text] [Related]

  • 14. The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria.
    Kaplan RA, Haussler MR, Deftos LJ, Bone H, Pak CY.
    J Clin Invest; 1977 May 04; 59(5):756-60. PubMed ID: 192763
    [Abstract] [Full Text] [Related]

  • 15. Vitamin D dependent rickets: decreased sensitivity to 1,25-dihydroxyvitamin D.
    Kudoh T, Kumagai T, Uetsuji N, Tsugawa S, Oyanagi K, Chiba Y, Minami R, Nakao T.
    Eur J Pediatr; 1981 Nov 04; 137(3):307-11. PubMed ID: 7318845
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Vitamin D metabolism in biliary atresia: intestinal absorptions of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3.
    Kimura S, Seino Y, Harada T, Nose O, Yamaoka K, Shimizu K, Tanaka H, Yabuuchi H, Fukui Y, Kamata S.
    J Pediatr Gastroenterol Nutr; 1988 Nov 04; 7(3):341-6. PubMed ID: 3260278
    [Abstract] [Full Text] [Related]

  • 18. Ability of 25-hydroxyvitamin D3 therapy to augment serum 1,25- and 24,25-dihydroxyvitamin D in postmenopausal osteoporosis.
    Lawoyin S, Zerwekh JE, Glass K, Pak CY.
    J Clin Endocrinol Metab; 1980 Mar 04; 50(3):593-6. PubMed ID: 6965678
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Treatment with high-dose oral vitamin D2 in patients with jejunoileal bypass for morbid obesity. Effects on calcium and magnesium metabolism, vitamin D metabolites, and faecal lag time.
    Charles P, Mosekilde L, Søndergård K, Jensen FT.
    Scand J Gastroenterol; 1984 Nov 04; 19(8):1031-8. PubMed ID: 6335925
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.